Driving Innovation Through Global Collaboration
DIA brings together regulators, industry leaders, academia, and patient communities to advance regulatory science and modernize medical product development. Through strategic research partnerships and multi-stakeholder consortia, we turn high-priority challenges into actionable solutions that improve efficiency, alignment, and patient access.
Our initiatives are built around focused scientific priorities and evolve from expert dialogue to structured consortia and funded research projects.
What Our Partners Are Saying
DIA's research and consortia bring together the full spectrum of stakeholders: patients, regulators, and industry professionals in a trusted, neutral environment.
I would highly recommend other patients and industry members to join DIA research efforts because of their integrity, collaborative and inclusive efforts related to research.
Greenphire was thrilled to be part of the DIA's Patient Engagement Tool research project, to partner with industry experts to explore the impact of these programs for those who matter most — trial participants.
DIA does a great job of organizing the right people at the table and facilitates great conversation among groups. It's a great reminder that achieving patient centricity needs to be worked on together.
Our Science Priorities
DIA develops research initiatives within the following priority areas.
AI and Real-World Evidence (RWE) in Medical Product Development
Optimizing Drug Development for Chronic Diseases, including obesity.
Precision Medicine & Improving Patient Access to Life-Saving Therapies
CMC Standards, Regulatory Convergence, and Patient Access
Innovative Approaches to Clinical Trials, Regulatory Reliance, and Global Collaboration
How Our Initiatives Evolve
From Dialogue to Impact — a structured pathway from expert insight to measurable outcomes.
Executive roundtables, DIAmond/DIAlogue sessions, and think tanks surface the field's highest-priority challenges.
Structured, multi-stakeholder collaboration around defined priority challenges with clear governance and shared goals.
Sponsored, advisory-guided initiatives with defined deliverables and measurable outcomes that advance the field.
Active Consortia & Research Projects
Browse active consortia and current research projects. Additional tiles will be added as new initiatives launch.
Patient-centered research initiative to redefine treatment tolerability in immuno-oncology.
Research study exploring the impact of participant compensation on clinical trial timelines and performance to guide best practices.
More information to come!
Initiatives in Development
DIA is continuously identifying emerging challenges and building the next generation of research initiatives. These efforts are in active development — shaped by expert input, stakeholder demand, and evolving science priorities.
in Pipeline